Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans

August 27, 2015 updated by: M.D. Anderson Cancer Center

Health Habits and Cancer Risk Among a US Migrant Sri Lankan Population and a Comparison With Siblings Living in Sri Lanka

Objectives:

General objective:

To determine how acculturation to United States has influenced the health and cancer risk among a US migrant Sri Lankan population.

Specific objectives:

  1. To determine the prevalence of cancer and cancer related non-communicable diseases among Sri Lankan Sinhalese living in the greater Houston area.
  2. To study the distribution of risk factors for cancer in this population.
  3. To study the pattern of utilization of methods available for early detection of cancer in this population.
  4. To study and compare the findings of this survey with that of the siblings of this population living in Sri Lanka.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

A health survey among Sinhala adults living in Houston comparing the health and health habits between the Sri Lankans living in Houston and their close relatives living in Sri Lanka.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sri Lanka
      • Peradeniya, Sri Lanka, 20400
        • University of Peradeniya
  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas MD Anderson Cancer Center
      • Houston, Texas, United States, 77054
        • City of Houston Department of Health and Human Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Sri Lankan Sinhalese adults (18 years of age or older) living in the greater Houston area, but born in Sri Lanka. Siblings or the first cousins of the study participants living in Sri Lanka of same sex and of an age plus or minus 10 years.

Description

Inclusion Criteria:

  1. Sri Lankan Sinhalese adults (18 years of age or older) living in the greater Houston area but born in Sri Lanka
  2. Siblings or the first cousins of the study participants living in Sri Lanka of same sex and of an age plus or minus 10 years

Exclusion Criteria:

  1. Sri Lankan Sinhalese born in the US
  2. Sri Lankan Sinhalese under 18 years of age
  3. Participation in a M. D. Anderson sponsored focus group or survey regarding health within the past 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sri Lankan Sinhalese
Sri Lankan Sinhalese adults (18 years of age or older) living in the greater Houston area, but born in Sri Lanka.
Behavioral: Questionnaire
Questions to collect health information specific to Sri Lankans.
Other Names:
  • Survey
Siblings or Cousins in Sri Lanka
Siblings or the first cousins of the study participants living in Sri Lanka of same sex and of an age plus or minus 10 years.
Behavioral: Questionnaire
Questions to collect health information specific to Sri Lankans.
Other Names:
  • Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Determine how acculturation to US has influenced health and cancer risk (prevalence of cancer related non-communicable diseases, distribution of risk factors, early cancer detection method utilization) among Sri Lankan Sinhalese in greater Houston area.
Time Frame: 3 Years
3 Years

Secondary Outcome Measures

Outcome Measure
Time Frame
To study and compare the findings of this survey with that of the siblings of this population living in Sri Lanka.
Time Frame: 1 Year
1 Year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Richard A. Hajek, PHD, MS, BA, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2007

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

May 21, 2007

First Submitted That Met QC Criteria

May 21, 2007

First Posted (Estimate)

May 22, 2007

Study Record Updates

Last Update Posted (Estimate)

August 28, 2015

Last Update Submitted That Met QC Criteria

August 27, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2006-1047

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acculturation

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe